Advert The study, presented at the recent ENDO 2025 conference, shows that obesity-associated breast cancer growth might be able to be combatted with the use of tirzepatide, adding another benefit to the originally diabetes-focused injection
The only wrinkle is some resolved regulatory history at one pharmacy partner, but nothing that raises active concern
Working with your provider on when and how to resume your regimen, once appetite stabilizes, is the approach described
Were here to help you feel confident and supported
Pregnancy, breastfeeding, severe gastrointestinal motility disorders, and a history of pancreatitis may also make these medications a poor fit
Clinical trials have indicated that semaglutide, coupled with lifestyle changes, can result in weight loss of 15-20% of total body weight, establishing it as one of the most impactful weight loss medications available